Literature DB >> 11432115

Triple-test screening in in vitro fertilization pregnancies.

I Bar-Hava1, M Yitzhak, H Krissi, M Shohat, J Shalev, B Czitron, Z Ben-Rafael, R Orvieto.   

Abstract

PURPOSE: To determine whether the results of triple-test analysis differ between spontaneous and IVF pregnancies.
METHODS: The study population consisted of 140 women with singleton pregnancies, 70 by IVF, and 70 by spontaneous conception. The groups were matched for maternal age, gestational week, and laboratory batch. The levels of all triple-test markers--alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and unconjugated estriol (u-E3)--were compared between the groups.
RESULTS: Significantly higher HCG levels were detected in the patients with IVF pregnancies than in the control group (1.31 +/- 0.8 vs. 0.95 +/- 0.5 multiple of the medians, respectively, (p < 0.006), but there were no significant differences in AFP or u-E3 levels. Overall, 18.5% of the IVF group were found to be screen-positive as compared with 11.4% of the control group (difference not statistically significant). Only 8 IVF pregnancies (11.4%) reached the lowest calculated risk possible (1:9999) compared with 17 (24.2%) in the control group (p < 0.05).
CONCLUSIONS: Our findings support previous data demonstrating elevated maternal serum HCG in IVF patients in comparison with spontaneous ones.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432115      PMCID: PMC3455369          DOI: 10.1023/a:1009455912670

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  12 in total

1.  Placental histology and the production of human choriogonadotrophin and its subunits in pregnancy.

Authors:  D L Hay
Journal:  Br J Obstet Gynaecol       Date:  1988-12

2.  Maternal serum screening for Down's syndrome in early pregnancy.

Authors:  N J Wald; H S Cuckle; J W Densem; K Nanchahal; P Royston; T Chard; J E Haddow; G J Knight; G E Palomaki; J A Canick
Journal:  BMJ       Date:  1988-10-08

3.  Alpha fetoprotein: Physiology and pathology during pregnancy and application to antenatal diagnosis.

Authors:  M Seppälä; E Ruoslahti
Journal:  J Perinat Med       Date:  1973       Impact factor: 1.901

4.  Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening.

Authors:  S Heinonen; M Ryynänen; P Kirkinen; M Hippeläinen; S Saarikoski
Journal:  Fertil Steril       Date:  1996-09       Impact factor: 7.329

5.  Down's syndrome screening marker levels following assisted reproduction.

Authors:  G Barkai; B Goldman; L Ries; R Chaki; J Dor; H Cuckle
Journal:  Prenat Diagn       Date:  1996-12       Impact factor: 3.050

6.  Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion.

Authors:  R P Marrs; O A Kletzky; W F Howard; D R Mishell
Journal:  Am J Obstet Gynecol       Date:  1979-11-15       Impact factor: 8.661

7.  Maternal serum screening for fetal Down syndrome in IVF pregnancies.

Authors:  L S Ribbert; L H Kornman; B T De Wolf; A H Simons; C A Jansen; J R Beekhuis; A Mantingh
Journal:  Prenat Diagn       Date:  1996-01       Impact factor: 3.050

8.  Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal deaths.

Authors:  F Muller; P Aegerter; A Boue
Journal:  Prenat Diagn       Date:  1993-01       Impact factor: 3.050

9.  Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level.

Authors:  H S Cuckle; N J Wald; S G Thompson
Journal:  Br J Obstet Gynaecol       Date:  1987-05

10.  An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities.

Authors:  I R Merkatz; H M Nitowsky; J N Macri; W E Johnson
Journal:  Am J Obstet Gynecol       Date:  1984-04-01       Impact factor: 8.661

View more
  5 in total

Review 1.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 2.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 3.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

Review 4.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 5.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.